Kentucky Retirement Systems Insurance Trust Fund lessened its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 9.6% in the third quarter, HoldingsChannel reports. The fund owned 17,417 shares of the financial services provider’s stock after selling 1,850 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in MetLife were worth $1,437,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently modified their holdings of the business. Orion Portfolio Solutions LLC raised its holdings in MetLife by 1.3% in the 1st quarter. Orion Portfolio Solutions LLC now owns 29,942 shares of the financial services provider’s stock valued at $2,219,000 after buying an additional 397 shares during the last quarter. First Foundation Advisors bought a new position in shares of MetLife in the first quarter valued at $72,000. Vanguard Group Inc. boosted its position in shares of MetLife by 3.4% during the first quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider’s stock valued at $4,418,612,000 after buying an additional 1,974,268 shares during the last quarter. Acadian Asset Management LLC bought a new stake in MetLife in the 1st quarter worth about $1,053,000. Finally, Edgestream Partners L.P. increased its position in shares of MetLife by 31.7% during the 1st quarter. Edgestream Partners L.P. now owns 7,002 shares of the financial services provider’s stock valued at $519,000 after purchasing an additional 1,684 shares during the last quarter. Institutional investors own 89.81% of the company’s stock.
MetLife Stock Up 0.9 %
MET stock opened at $83.33 on Friday. The company has a market cap of $57.70 billion, a price-to-earnings ratio of 16.80, a P/E/G ratio of 0.76 and a beta of 1.05. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The business’s 50-day moving average is $81.60 and its two-hundred day moving average is $75.59. MetLife, Inc. has a fifty-two week low of $61.61 and a fifty-two week high of $86.94.
MetLife Dividend Announcement
Analyst Ratings Changes
MET has been the topic of a number of analyst reports. Citigroup boosted their target price on shares of MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Jefferies Financial Group raised their price target on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. Wells Fargo & Company raised their price target on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Morgan Stanley reduced their target price on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. Finally, StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th. Fourteen equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $88.46.
Get Our Latest Stock Report on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- How to Calculate Stock Profit
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Plot Fibonacci Price Inflection Levels
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Why Are Stock Sectors Important to Successful Investing?
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.